The 6th PREDiCT: 3D Tissue Models Summit is the only industry-led summit focusing on real-world application of 3D models in drug discovery and development. With 25+ experts sharing fresh case studies on 3D Tissue Models data, how to foster technology maturation, and lower costs to drive industrial adoption, this is a conversation not to miss.
Our 2021 program will delve further into advanced 3D organoids, organ-on-chips, microphysiological systems (MPS), and tissue engineering - from oncology to other therapeutic areas such as neurodegenerative, respiratory, fibrosis, and the cardiovascular fields. Explore preclinical safety and toxicology models and translation in clinical Ph1 for biomarkers and patient stratification for better Ph2 design.
Join over 120+ senior leaders including Pfizer, Takeda, GSK, Roche, and FDA in September, to re-engage in the dialogue and discuss journeys and lessons learned with complex in vitro models, compared with conventional in vivo and 2D cell studies.
Our 2021 program will delve further into advanced 3D organoids, organ-on-chips, microphysiological systems (MPS), and tissue engineering - from oncology to other therapeutic areas such as neurodegenerative, respiratory, fibrosis, and the cardiovascular fields. Explore preclinical safety and toxicology models and translation in clinical Ph1 for biomarkers and patient stratification for better Ph2 design.
Join over 120+ senior leaders including Pfizer, Takeda, GSK, Roche, and FDA in September, to re-engage in the dialogue and discuss journeys and lessons learned with complex in vitro models, compared with conventional in vivo and 2D cell studies.
